Digital ecosystem for customized patient care of the future

New technologies lead us to an unprecedented understanding of a best possible, result-oriented treatment.

ID: 1560993
recent pressrelease next pressrelease

(PresseBox) - .

In order to guarantee the best possible therapy for patients, medical products must be constantly improved. Therefore, a nationwide project was launched in 2020. The AIQNET project aims to develop a digital ecosystem for medical data.

In future, AIQNET aims to make medical data more exchangeable and usable for research, diagnosis and treatment. Artificial intelligence will be used to automate data analysis and structuring. Dr. Ina W& Medical Scientific Affairs at Aesculap AG, explains in the following interview which advantages the new global ecosystem might bring for patients, doctors and manufacturers.

Why did a global player like Aesculap decide to support a digital ecosystem like AIQNET? What are the advantages?

Dr. Ina W

What expectations do you have of AIQNET and the cooperation with other partners?

Dr. Ina Wt the same time, it provides a safe legal framework ? e.g. protection of personal data - and a technically safe infrastructure, namely cybersecurity.

An "ecosystem" lives from its stakeholders - the current and future project partners. Our expectation is therefore an effective collaboration to provide patients and users with safe and efficient medical products.

How does AIQNET benefit the patient?

Dr. Ina Win interaction with patients and users. This allows insight into the effect of biological and technical parameters on the treatment outcome. If, for example, a patient is suffering from an identified risk factor prior to the medical intervention, the physician can take preparatory action instead of having to react to a complication. If, for example, weaknesses in products become frequently apparent, it results in targeted product development. Consequently, all these factors have a positive effect on patient care.

Which aspects of the project are particularly important to you?

Dr. Ina W"new" technologies lead us to an unprecedented understanding of a best possible, result-oriented treatment and future-oriented partnership with all parties involved. B. Braun Aesculap, with its guiding principle of Sharing Expertise, aims to be both a pioneer and a role model in this field.



It enables manufacturers to objectively measure and compare the performance and safety of medical products in accordance with European legislation. The open platform offers partners the opportunity to develop their own healthcare applications and make them available to different users, including patients.

Source: https://www.biolago.org/en/2020/09/23/digital-ecosystem-for-customized-patient-care-of-the-future/

AIQNET is an emerging, transnational, digital ecosystem with the potential to revolutionize healthcare. By utilizing artificial intelligence, medical data will be made exchangeable and thus become available for research, diagnosis and treatment. Manufacturers will be able to objectively measure and compare the performance and safety of their medical devices in accordance with European legislation. The open platform offers partners the opportunity to develop their own health applications and make them available to different users, including patients. Funded by the German Federal Ministry for Economic Affairs and Energy (BMWi), the platform is currently under developed with first applications by 16 partners. Additional partners are welcome. BioRegio STERN Management GmbH coordinates the KIKS project, which is under the consortium leadership of RAYLYTIC GmbH.



More information:
http://https://



Keywords (optional):



Company information / Profile:

AIQNET is an emerging, transnational, digital ecosystem with the potential to revolutionize healthcare. By utilizing artificial intelligence, medical data will be made exchangeable and thus become available for research, diagnosis and treatment. Manufacturers will be able to objectively measure and compare the performance and safety of their medical devices in accordance with European legislation. The open platform offers partners the opportunity to develop their own health applications and make them available to different users, including patients. Funded by the German Federal Ministry for Economic Affairs and Energy (BMWi), the platform is currently under developed with first applications by 16 partners. Additional partners are welcome. BioRegio STERN Management GmbH coordinates the KIKS project, which is under the consortium leadership of RAYLYTIC GmbH.

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 09/23/2020 - 10:51
Language: English
News-ID 1560993
Character count: 5123
Kontakt-Informationen:
Firma: AIQNET
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Leipzig
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 157

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 70


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.